Search research articles
Contact Us
Filters
Showing results (101-110 of 152) with videos related to
Page
of 16
Sort By:
Oncotarget
|
April 16, 2016
Sequential intensified conditioning followed by prophylactic DLI could reduce relapse of refractory acute leukemia after allo-HSCT
Li Xuan, Zhiping Fan, Yu Zhang, et al.
International Journal of Cancer
|
April 26, 2021
Upfront transplantation may have better outcomes than pretransplant cytoreductive therapy for treating patients with MDS-EB-1 or MDS-EB-2
Yili Chen, Fen Huang, Li Xuan, et al.
Journal of Hematology & Oncology
|
February 12, 2013
Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and multicenter study
Hui Liu, Xiao Zhai, Zhaoyang Song, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 11, 2014
Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation
Ke Zhao, Rui Lou, Fen Huang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 13, 2019
Intestinal Microbiota Can Predict Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation
Lijie Han, Haiyan Zhang, Shan Chen, et al.
Plos One
|
October 15, 2013
Herpesvirus-associated central nervous system diseases after allogeneic hematopoietic stem cell transplantation
Meiqing Wu, Fen Huang, Xinmiao Jiang, et al.
Cancer Letters
|
April 26, 2021
Allogeneic hematopoietic cell transplant overcomes the poor prognostic value of CDKN2 deletion in adult B-lineage acute lymphoblastic leukemia
Yiwen Ling, Na Xu, Ke Zhao, et al.
Ebiomedicine
|
November 1, 2019
The efficacy of mesenchymal stem cells in bronchiolitis obliterans syndrome after allogeneic HSCT: A multicenter prospective cohort study
Shan Chen, Ke Zhao, Ren Lin, et al.
Cell Transplantation
|
January 9, 2013
Improvement in poor graft function after allogeneic hematopoietic stem cell transplantation upon administration of mesenchymal stem cells from third-party donors: a pilot prospective study
Xiaodan Liu, Meiqing Wu, Yanwen Peng, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 29, 2014
Antifungal agents for secondary prophylaxis based on response to initial antifungal therapy in allogeneic hematopoietic stem cell transplant recipients with prior pulmonary aspergillosis
Qifa Liu, Ren Lin, Jing Sun, et al.
Page
of 16
Search research articles
Search
Showing results (101-110 of 152) with videos related to
Sort By:
Page
of 16
Oncotarget
|
April 16, 2016
Sequential intensified conditioning followed by prophylactic DLI could reduce relapse of refractory acute leukemia after allo-HSCT
Li Xuan, Zhiping Fan, Yu Zhang, et al.
International Journal of Cancer
|
April 26, 2021
Upfront transplantation may have better outcomes than pretransplant cytoreductive therapy for treating patients with MDS-EB-1 or MDS-EB-2
Yili Chen, Fen Huang, Li Xuan, et al.
Journal of Hematology & Oncology
|
February 12, 2013
Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and multicenter study
Hui Liu, Xiao Zhai, Zhaoyang Song, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 11, 2014
Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation
Ke Zhao, Rui Lou, Fen Huang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 13, 2019
Intestinal Microbiota Can Predict Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation
Lijie Han, Haiyan Zhang, Shan Chen, et al.
Plos One
|
October 15, 2013
Herpesvirus-associated central nervous system diseases after allogeneic hematopoietic stem cell transplantation
Meiqing Wu, Fen Huang, Xinmiao Jiang, et al.
Cancer Letters
|
April 26, 2021
Allogeneic hematopoietic cell transplant overcomes the poor prognostic value of CDKN2 deletion in adult B-lineage acute lymphoblastic leukemia
Yiwen Ling, Na Xu, Ke Zhao, et al.
Ebiomedicine
|
November 1, 2019
The efficacy of mesenchymal stem cells in bronchiolitis obliterans syndrome after allogeneic HSCT: A multicenter prospective cohort study
Shan Chen, Ke Zhao, Ren Lin, et al.
Cell Transplantation
|
January 9, 2013
Improvement in poor graft function after allogeneic hematopoietic stem cell transplantation upon administration of mesenchymal stem cells from third-party donors: a pilot prospective study
Xiaodan Liu, Meiqing Wu, Yanwen Peng, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 29, 2014
Antifungal agents for secondary prophylaxis based on response to initial antifungal therapy in allogeneic hematopoietic stem cell transplant recipients with prior pulmonary aspergillosis
Qifa Liu, Ren Lin, Jing Sun, et al.
Page
of 16